Stryker director sells 350K shares in trust trades
STRYKER CORP (SYK) director Ronda E. Stryker reported open-market sales of 350,000 shares of common stock on August 18–19, 2026, through a revocable trust, at weighted average prices generally between $331.15 and $343.90 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
STRYKER CORP (SYK) director Ronda E. Stryker reported open-market sales of 350,000 shares of common stock on August 18–19, 2026, through a revocable trust, at weighted average prices generally between $331.15 and $343.90 per share. After these transactions, she reports holdings of 12,177,521 shares indirectly via the L. Lee Stryker Trust, 37,600 shares indirectly via the 1988 William D. Johnston Trust, and 762 shares held directly.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F10 | 40 | $331.805 | $13K |
| Sale | Common Stock F11 | 440 | $333.177 | $147K |
| Sale | Common Stock F12 | 200 | $333.931 | $67K |
| Sale | Common Stock F13 | 80 | $335.055 | $27K |
| Sale | Common Stock F14 | 320 | $336.793 | $108K |
| Sale | Common Stock F15 | 2,308 | $337.982 | $780K |
| Sale | Common Stock F16 | 11,257 | $338.899 | $3.81M |
| Sale | Common Stock F17 | 10,812 | $339.71 | $3.67M |
| Sale | Common Stock F18 | 16,612 | $340.706 | $5.66M |
| Sale | Common Stock F19 | 3,274 | $341.839 | $1.12M |
| Sale | Common Stock F20 | 3,852 | $342.797 | $1.32M |
| Sale | Common Stock F21 | 805 | $343.472 | $276K |
| Sale | Common Stock F1, F2 | 2,239 | $331.742 | $743K |
| Sale | Common Stock F3 | 2,920 | $332.694 | $971K |
| Sale | Common Stock F4 | 8,404 | $333.825 | $2.81M |
| Sale | Common Stock F5 | 25,536 | $334.945 | $8.55M |
| Sale | Common Stock F6 | 131,752 | $335.642 | $44.22M |
| Sale | Common Stock F7 | 109,425 | $336.433 | $36.81M |
| Sale | Common Stock F8 | 16,243 | $337.629 | $5.48M |
| Sale | Common Stock F9 | 3,481 | $338.498 | $1.18M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (21)
- F1. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $331.15 to $332.11, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F2. Includes 560 shares previously held directly which were transferred to the Revocable Trust on August 18, 2026.
- F3. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $332.17 to $333.085, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F4. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $333.16 to $334.14, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F5. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $334.21 to $335.145, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F6. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $335.15 to $336.145, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F7. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $336.15 to $337.145, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F8. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $337.15 to $338.13, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F9. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $338.15 to $339.10, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F10. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $331.74 to $332.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F11. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $332.81 to $333.775, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F12. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $333.81 to $334.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F13. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $335.05 to $335.06, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F14. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $336.20 to $337.14, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F15. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $337.31 to $338.255, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F16. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $338.30 to $339.295, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F17. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $339.30 to $340.295, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F18. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $340.30 to $341.27, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F19. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $341.30 to $342.295, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F20. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $342.32 to $343.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F21. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $343.31 to $343.90, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Key Figures
Key Terms
weighted average sale price financial
Revocable Trust financial
indirect ownership financial
open market or private transaction financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SYK director Ronda E. Stryker report in this Form 4?
Were the SYK trades under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.